Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
Yuying Zhang, Laboratory Medicine and Pathobiology PhD Candidate at University of Toronto, shared on LinkedIn:
”I am very grateful to have given my first conference oral presentation at the 2026 Canadian Society for Transfusion Medicine Annual Conference in Hamilton.
I presented one of my PhD research project on targeting human CD44 as a potential plasma-independent alternative to IVIg in immune thrombocytopenia.
This was a meaningful milestone for me as my first oral presentation at a conference.
I really appreciated the opportunity to share my work, receive thoughtful questions, and connect with the transfusion medicine community.
A huge thank you to my supervisor Dr. Alan H. Lazarus, my mentor Alequis Pavon Oro, my supportive lab members, the vivarium staff, the research core facilities at the Keenan Research Centre for Biomedical Science and my thesis advisory committee members.
I am also grateful to Canadian Blood Services, Mitacs, the UofT Department of Laboratory Medicine & Pathobiology for their support.
Excited to keep learning, improving, and moving forward.”

Stay updated with Hemostasis Today.
-
Sep 13, 2026, 05:36Speaking Up When Women’s Health Concerns Are Dismissed – Haemophilia Foundation Australia
-
Sep 13, 2026, 05:16W. Alberto Sifuentes Giraldo: Dual Targeted Therapy Shows Promise in Refractory Systemic Autoinflammatory Diseases
-
Sep 13, 2026, 04:42Christopher Robinson: Early Pregnancy Oxylipins May Signal Risk of Fetal Growth Restriction
-
Sep 13, 2026, 04:22Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
-
Sep 13, 2026, 03:40Mizinga Moonze: When Blood Speaks – The Missing Link in Healthcare Sustainability
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?